GeLongHui October 28th | Xiao Fang Pharmaceuticals (603207.SH) announced the third quarter report of 2024, with a revenue of 0.367 billion yuan for the first three quarters, a year-on-year increase of 0.05%; net income attributable to shareholders of the listed company was 0.162 billion yuan, a year-on-year decrease of 4.07%; and basic earnings per share was 1.28 yuan.
小方制药(603207.SH)：前三季度净利润1.62亿元，同比下降4.07%
Xiaofang Pharmaceutical (603207.SH): The net income in the first three quarters was 0.162 billion yuan, a 4.07% decrease compared to the same period last year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated